CHIR99021, trough GSK-3β Targeting, Reduces Epithelioid Sarcoma Cell Proliferation by Activating Mitotic Catastrophe and Autophagy

Epithelioid sarcoma (ES) is a rare disease representing <1% of soft tissue sarcomas. Current therapies are based on anthracycline alone or in combination with ifosfamide or other cytotoxic drugs. ES is still characterized by a poor prognosis with high rates of recurrence. Indeed, for years, ES su...

Descripción completa

Detalles Bibliográficos
Autores principales: Russi, Sabino, Sgambato, Alessandro, Bochicchio, Anna Maria, Zoppoli, Pietro, Aieta, Michele, Capobianco, Alba Maria Lucia, Ruggieri, Vitalba, Zifarone, Emanuela, Falco, Geppino, Laurino, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538073/
https://www.ncbi.nlm.nih.gov/pubmed/34681807
http://dx.doi.org/10.3390/ijms222011147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538073/
https://www.ncbi.nlm.nih.gov/pubmed/34681807
http://dx.doi.org/10.3390/ijms222011147

Ejemplares similares